Here is a two-part series I put together, using Roaring Kitty’s GameStop story as a frame for what is unfolding with Northwest Biotherapeutics. The first part looks at how a well-researched position can be held down by market structure for long periods, even when the fundamentals are advancing. GameStop proved that when those conditions change, the price can move hard and fast.
The second part applies that lens to NWBO. The company is advancing a late-stage cancer therapy toward approval with clear regulatory progress, yet the stock remains under heavy short pressure. That gap between the science and the market is familiar to anyone who watched GameStop before its turn.
The parallels are obvious. Only this time it is a company advancing a cancer cure, so you do the math. I am sure all the shills on this site already have.
Market Data 
Markets 
AI
